ShockWave Medical, Inc. (SWAV)

NASDAQ: SWAV · IEX Real-Time Price · USD
187.32
-2.17 (-1.15%)
At close: Feb 3, 2023, 4:00 PM
187.90
+0.58 (0.31%)
After-hours: Feb 3, 2023, 7:58 PM EST
-1.15%
Market Cap 6.77B
Revenue (ttm) 429.89M
Net Income (ttm) 88.03M
Shares Out 36.14M
EPS (ttm) 2.36
PE Ratio 79.37
Forward PE 61.73
Dividend n/a
Ex-Dividend Date n/a
Volume 379,750
Open 187.23
Previous Close 189.49
Day's Range 185.06 - 190.66
52-Week Range 113.36 - 320.54
Beta 1.04
Analysts Buy
Price Target 264.69 (+41.3%)
Earnings Date Feb 16, 2023

About SWAV

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists thro... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Mar 7, 2019
Employees 657
Stock Exchange NASDAQ
Ticker Symbol SWAV
Full Company Profile

Financial Performance

In 2021, SWAV's revenue was $237.15 million, an increase of 249.83% compared to the previous year's $67.79 million. Losses were -$9.14 million, -86.09% less than in 2020.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for SWAV stock is "Buy." The 12-month stock price forecast is $264.69, which is an increase of 41.30% from the latest price.

Price Target
$264.69
(41.30% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status

Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not Recommended Guidance Expands Number of Hospitals that Can Access IVL to I...

5 days ago - GlobeNewsWire

3 Pharma Stocks That Will Mint Millionaires

In recent weeks, the Street has become much more enamored with pharma stocks than it was previously. The iShares Biotechnology ETF (NASDAQ: IBB) climbed 6% so far this year.

Other symbols: IMCRRVNC
6 days ago - InvestorPlace

Mergers and Acquisitions in 2023 Off To A Strong Start

Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $...

1 week ago - MarketBeat

ShockWave Medical (SWAV) Posts Solid Preliminary Q4 Revenues

ShockWave Medical's (SWAV) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its U.S. Coronary business.

2 weeks ago - Zacks Investment Research

Shockwave Medical's (SWAV) New Buyout to Boost Patient Outcome

Shockwave Medical's (SWAV) latest acquisition is expected to serve a wider patient pool.

2 weeks ago - Zacks Investment Research

Can Shockwave Medical (SWAV) Keep the Earnings Surprise Streak Alive?

Shockwave Medical (SWAV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 weeks ago - Zacks Investment Research

Shockwave Medical to Acquire Neovasc

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for t...

Other symbols: NVCN
2 weeks ago - Newsfile Corp

Shockwave Medical Announces Agreement to Acquire Neovasc

Neovasc's Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market

2 weeks ago - GlobeNewsWire

Is the Options Market Predicting a Spike in ShockWave Medical (SWAV) Stock?

Investors need to pay close attention to ShockWave Medical (SWAV) stock based on the movements in the options market lately.

1 month ago - Zacks Investment Research

Shockwave Medical Provides Quarterly Earnings Release Dates for 2023

SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca...

1 month ago - GlobeNewsWire

The 7 Best Retirement Stocks for Investors Over 50

The best retirement stocks for investors over 50 have reliability in common. Retirement stocks come in a few flavors, but the best retirement stocks for investors over 50 provide a mix of growth, stab...

Other symbols: DVNLLYLNGOXYSQMXOM
1 month ago - InvestorPlace

Here's Why You Should Bet on ShockWave Medical (SWAV) Stock

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

1 month ago - Zacks Investment Research

Top 5 Non-Tech Nasdaq Winners of 2022 With More Upside Left

we have identified five non-technology Nasdaq stocks that have popped in 2022 despite the index's blood bath. These are: UTHR, LPLA, ENPH, SWAV, CHX.

Other symbols: CHXENPHLPLAUTHR
1 month ago - Zacks Investment Research

After Plunging 10.9% in 4 Weeks, Here's Why the Trend Might Reverse for Shockwave Medical (SWAV)

Shockwave Medical (SWAV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

1 month ago - Zacks Investment Research

Why Is Shockwave Medical (SWAV) Down 8.3% Since Last Earnings Report?

Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

3 Medical Instruments Stocks With Potential to Outperform

Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.

Other symbols: IRMDTCMD
2 months ago - Zacks Investment Research

3 Medical Instruments Stocks to Buy as Inflation Clouds Prospects

The Zacks Medical - Instruments industry is growing on rising demand for digital health. SWAV, MLAB and DYNT are set to gain the most.

Other symbols: DYNTMLAB
2 months ago - Zacks Investment Research

Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference

SANTA CLARA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascula...

2 months ago - GlobeNewsWire

Shockwave Medical Publishes Inaugural ESG Report

SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascula...

2 months ago - GlobeNewsWire

Shockwave Medical (SWAV) Beats on Q3 Earnings & Revenues

Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and expansion in gross margin.

3 months ago - Zacks Investment Research

Shockwave Medical (SWAV) Q3 Earnings and Revenues Beat Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 35.29% and 4.36%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shockwave Medical Reports Third Quarter 2022 Financial Results

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca...

3 months ago - GlobeNewsWire

What's in Store for Shockwave Medical (SWAV) in Q3 Earnings?

Shockwave Medical's (SWAV) third-quarter results are likely to reflect solid performance of its IVL system across geographies.

3 months ago - Zacks Investment Research

Two stocks that are ‘immune' to what the Fed does

Fed Chair Jerome Powell made it somewhat clear this week that “pausing” was not an option just yet. (read more) That paints a not-so-healthy picture for stocks moving forward.

Other symbols: CZR
3 months ago - Invezz

Three stocks that allow investors forget about the Fed, according to strategist Peter Andersen

Peter Andersen, chief investment officer at Andersen Capital Management, joins 'Power Lunch' to discuss Fed guidance, stocks that show interest rate resilience, and investments in innovative technolog...

Other symbols: CZR
3 months ago - CNBC Television